Innovation Hub / Podcasts
#ExpertAnswers: Victor Arrieta on Anti-PD-1 Immunotherapy for Recurrent Glioblastoma
January 2, 2024
Dr. V√≠ctor Andrés Arrieta explores how p-ERK activation links to better survival in rGBM patients treated with anti-PD-1 immunotherapy.
Weekly News Roundup - PhRMA Leadership Transition, The ICHRA Shift, and MDUFA VI Preliminary Deal
Talking Real Science with Stella Goulopoulou
Talking Real Science with Yelena Akelina
#ExpertAnswers: Catherine Ewen on Setting Up DC and CD8+ T Cell Co-culture Experiments
Talking Real Science with Licy Yanes Cardozo
Industry Insights with Bas Trietsch and STEMCELL Technologies
Talking Real Science with Helen Collins
Talking Real Science with Rachel Buckley
Talking Real Science with Meaghan Loy on Rare Disease Day